Regeneron Pharmaceuticals, Inc. discretely revealed its intentions to expand its Anti-SARS-CoV-2 Monoclonal Antibody offerings at the J.P. Morgan Healthcare Conference on January 9, 2023.
stop it man .. lol .. seems the cat will be coming out of the bag very soon .. day dreamin' away here .. speculative a bit maybe .. but you don't need to be a rocket scientist to see the connection!!!!!!!!!!!!!!!!